Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statement of Changes in Stockholders' Equity (Unaudited)

v3.20.1
Condensed Consolidated Statement of Changes in Stockholders' Equity (Unaudited) - USD ($)
$ in Thousands
Total
Preferred Stock
Common Stock
Additional Paid-in Capital
Retained Earnings (Accumulated Deficit)
Accumulated Other Comprehensive Income
Total New Residential Stockholders’ Equity
Noncontrolling Interests in Equity of Consolidated Subsidiaries
Common Stock
Common Stock
Common Stock
Common Stock
Additional Paid-in Capital
Common Stock
Total New Residential Stockholders’ Equity
Preferred Stock
Preferred Stock
Preferred Stock
Preferred Stock
Total New Residential Stockholders’ Equity
Cumulative Effect, Period of Adoption, Adjustment
Cumulative Effect, Period of Adoption, Adjustment
Retained Earnings (Accumulated Deficit)
Cumulative Effect, Period of Adoption, Adjustment
Total New Residential Stockholders’ Equity
Cumulative Effect, Period of Adoption, Adjustment
Noncontrolling Interests in Equity of Consolidated Subsidiaries
Equity, beginning balance (in shares) at Dec. 31, 2018   0 369,104,429                                
Equity, beginning balance at Dec. 31, 2018 $ 6,088,295 $ 0 $ 3,692 $ 4,746,242 $ 830,713 $ 417,023 $ 5,997,670 $ 90,625                      
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                      
Dividends declared on common stock (in dollars per share) (207,715)       (207,715)   (207,715)                        
Capital contributions 0                                    
Capital distributions (11,015)             (11,015)                      
Issuance of stock (in shares)     46,000,000                                
Issuance of stock 751,659   $ 460 751,199     751,659                        
Options exercise (in shares)     297,096                                
Option exercise     $ 3 (3)                              
Purchase of noncontrolling interests 0                                    
Other dilution 0                                    
Director share grants (in shares)     28,152                                
Director share grants 400     400     400                        
Comprehensive income (loss)                                      
Net income (loss) 155,912       145,594   145,594 10,318                      
Net unrealized gain (loss) on securities 192,353         192,353 192,353                        
Reclassification of net realized (gain) loss on securities into earnings (57,680)         (57,680) (57,680)                        
Total comprehensive income (loss) 290,585           280,267 10,318                      
Equity, ending balance (in shares) at Mar. 31, 2019   0 415,429,677                                
Equity, ending balance at Mar. 31, 2019 6,912,209 $ 0 $ 4,155 5,497,838 768,592 551,696 6,822,281 89,928                      
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                      
Cumulative adjustment for the adoption of ASU 2016-13 549,733                             $ 30,453 $ 13,658 $ 13,658 $ 16,795
Equity, beginning balance (in shares) at Dec. 31, 2019   17,510,000 415,520,780                                
Equity, beginning balance at Dec. 31, 2019 7,236,260 $ 423,444 $ 4,156 5,498,226 549,733 682,151 7,157,710 78,550                      
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                      
Dividends declared on common stock (in dollars per share) (20,782)       (20,782)   (20,782)                        
Dividends declared on preferred stock (11,222)       (11,222)   (11,222)                        
Capital distributions $ (12,605)             (12,605)                      
Issuance of stock (in shares)   16,100,000               97,394                  
Issuance of stock                 $ 1,583 $ 1 $ 1,582 $ 1,583 $ 389,548 $ 389,548 $ 389,548        
Options exercise (in shares) 0                                    
Director share grants (in shares)     31,040                                
Director share grants $ 500     500     500                        
Comprehensive income (loss)                                      
Net income (loss) (1,607,255)       (1,591,093)   (1,591,093) (16,162)                      
Net unrealized gain (loss) on securities 34,375         34,375 34,375                        
Reclassification of net realized (gain) loss on securities into earnings (710,391)         (710,391) (710,391)                        
Total comprehensive income (loss) (2,283,271)           (2,267,109) (16,162)                      
Equity, ending balance (in shares) at Mar. 31, 2020   33,610,000 415,649,214                                
Equity, ending balance at Mar. 31, 2020 5,330,464 $ 812,992 $ 4,157 $ 5,500,308 $ (1,059,706) $ 6,135 $ 5,263,886 $ 66,578                      
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                      
Cumulative adjustment for the adoption of ASU 2016-13 $ (1,059,706)